Press Releases from Imanova (3 total)
The power of combining DREADD and PET imaging technologies to be presented for t …
DREADD (Designer Receptors Exclusively Activated by Designer Drugs) technology is an exciting chemogenetic tool allowing the hijacking of neurons by a molecular switch to remotely…
Further Growth in Imanova’s Preclinical Biology Offering
Imanova is pleased to announce further expansion of its preclinical team, with the addition of new roles in both Chemistry and Biology. These new roles…
Imanova plays central role in world’s most in-depth study to detect Alzheimerâ …
London, August 2016: A new multimillion-pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on…
Go To Page:
